The Valley Desk

NCT04862663 · Interventional trial

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

Overall registry status Active not recruiting

Phase 3

Conditions Locally Advanced (Inoperable) or Metastatic Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov